Rimegepant Sulfate Patent Expiration
Rimegepant Sulfate is Used for preventing episodic migraine in adults. It was first introduced by Pfizer Inc
Rimegepant Sulfate Patents
Given below is the list of patents protecting Rimegepant Sulfate, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Nurtec Odt | US11083724 | Rimegepant for CGRP related disorders | Mar 25, 2039 | Pfizer |
| Nurtec Odt | US8759372 | N-(5S,6S,9R)-amino-6-(2,3-difluorophenyl)-6,7,8,9-tetrahydro-5H-ctclohepta[b]Pyridin-9-yl-4-(2-oxo-2,3-dihydro-1H-imidazo[4,5-b]pyridin-1-carboxylate salt | Feb 25, 2033 | Pfizer |
| Nurtec Odt | US8314117 | CGRP receptor antagonists | Mar 09, 2030 | Pfizer |
Rimegepant Sulfate's Family Patents
Explore Our Curated Drug Screens
Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List